JCB logo
CrossRef
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 21 March 2005. doi:10.1083/jcb1687rr3
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 168, Number 7, 986-987
This Article
Right arrow Full Text (PDF, 265K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Roundup

PML goes to the centrosome


The promyelocytic leukemia gene (PML) has "too many things it is involved in," says Kun-Sang Chang (University of Texas MD Anderson Cancer Center, Houston, TX). But now Chang, Zhi-Xiang Xu, and colleagues have added another function: the PML3 isoform prevents centrosome reduplication.

PML has at least 7 isoforms but most studies have used only one (PML4). Chang developed isoform-specific antibodies and saw that PML3 antibodies gave staining that coincided with that of centrosome proteins. Knock-down by siRNA of PML3, but not of other PML isoforms, resulted in centrosome amplification. And only PML3 interacted with and, when overexpressed, reduced the phosphorylation of Aurora A kinase.

It is known that in cells with activated Aurora A kinase there is a failure to inhibit Cdk2/cyclin E, leading to reduplication of centrosomes. Cells lacking PML had higher levels of Cdk2 kinase activity, which could explain the centrosome reduplication. What is signaling to PML from upstream is still mysterious, but the new findings certainly provide one possible explanation for why PML is lost in so many tumor types. {rr_end}

Reference:

Xu, Z.-X., et al. 2005. Mol. Cell. 17:721–732.[CrossRef][Medline]



William A. Wells

wellsw{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 265K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents